SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-073986
Filing Date
2018-12-20
Accepted
2018-12-20 10:22:40
Documents
7
Period of Report
2018-12-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-41925_18k.htm 8-K 43821
2 EX-10.1 a18-41925_1ex10d1.htm EX-10.1 230812
3 EX-10.2 a18-41925_1ex10d2.htm EX-10.2 81851
4 EX-10.3 a18-41925_1ex10d3.htm EX-10.3 14720
5 EX-99.1 a18-41925_1ex99d1.htm EX-99.1 23832
6 GRAPHIC g419251lc01i001.gif GRAPHIC 94
7 GRAPHIC g419251mmi001.jpg GRAPHIC 6447
  Complete submission text file 0001104659-18-073986.txt   405700
Mailing Address 240 LEIGH FARM ROAD DURHAM NC 27707
Business Address 240 LEIGH FARM ROAD DURHAM NC 27707 919-806-4487
Dova Pharmaceuticals Inc. (Filer) CIK: 0001685071 (see all company filings)

IRS No.: 813858961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38135 | Film No.: 181245012
SIC: 2834 Pharmaceutical Preparations